497 followers
RT @BiotechRadar: same objective as this week's MSKCC paper (but published 3wks ago!) Increased antitumor activities of glypican-3-specifi…
3,940 followers
RT @BiotechRadar: same objective as this week's MSKCC paper (but published 3wks ago!) Increased antitumor activities of glypican-3-specifi…
1,002 followers
RT @BiotechRadar: same objective as this week's MSKCC paper (but published 3wks ago!) Increased antitumor activities of glypican-3-specifi…
248 followers
RT @BiotechRadar: same objective as this week's MSKCC paper (but published 3wks ago!) Increased antitumor activities of glypican-3-specifi…
15,675 followers
same objective as this week's MSKCC paper (but published 3wks ago!) Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein https://t.co/pWosWHwTnX https://t.co
114 followers
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein. https://t.co/lwkDmI2NY9 https://t.co/0eWpT7ZwUe
257 followers
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein. https://t.co/eRgcdpTchd